Nwam LLC Abb Vie Inc. Transaction History

Nwam LLC

$1.6 Billion
Q3 2024

A detailed history of Nwam LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Nwam LLC holds 20,280 shares of ABBV stock, worth $3.57 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

20,280

Previous 15,415 31.56%

Holding current value

$3.57 Million

Previous $2.64 Million 51.49%

% of portfolio

0.25%

Previous 0.78%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $797,081 - $969,740	4,865 Added 31.56%	20,280 $4 Million
Q2 2024 Jul 23, 2024	BUY	$154.79 - $180.76 $835,401 - $975,561	5,397 Added 53.87%	15,415 $2.64 Million
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $786,154 - $895,749	-4,919 Reduced 32.93%	10,018 $1.82 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $28,758 - $32,388	-209 Reduced 1.38%	14,937 $2.31 Million
Q3 2023 Oct 31, 2023	BUY	$133.59 - $154.65 $9,217 - $10,670	69 Added 0.46%	15,146 $2.26 Million
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $839,715 - $1.04 Million	6,337 Added 72.51%	15,077 $2.03 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $926,950 - $1.07 Million	-6,410 Reduced 42.31%	8,740 $1.39 Million
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $103,317 - $123,904	-747 Reduced 4.7%	15,150 $2.45 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $96,362 - $110,521	718 Added 4.73%	15,897 $2.13 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $235,743 - $299,706	-1,713 Reduced 10.14%	15,179 $2.33 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $137,523 - $170,627	1,042 Added 6.57%	16,892 $2.74 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $284,367 - $359,806	2,647 Added 20.05%	15,850 $2.15 Million
Q3 2021 Nov 03, 2021	BUY	$106.4 - $120.78 $17,130 - $19,445	161 Added 1.23%	13,203 $1.42 Million
Q2 2021 Aug 04, 2021	SELL	$105.21 - $117.21 $112,364 - $125,180	-1,068 Reduced 7.57%	13,042 $1.47 Million
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $171,864 - $189,201	1,680 Added 13.52%	14,110 $1.53 Million
Q4 2020 Jan 22, 2021	SELL	$80.49 - $108.67 $101,497 - $137,032	-1,261 Reduced 9.21%	12,430 $1.33 Million
Q3 2020 Oct 16, 2020	SELL	$85.91 - $100.83 $2.41 Million - $2.82 Million	-28,005 Reduced 67.16%	13,691 $1.2 Million
Q2 2020 Jul 21, 2020	BUY	$73.37 - $98.18 $1.55 Million - $2.07 Million	21,100 Added 102.45%	41,696 $4.09 Million
Q1 2020 Apr 16, 2020	SELL	$64.5 - $97.79 $91,009 - $137,981	-1,411 Reduced 6.41%	20,596 $1.57 Million
Q4 2019 Jan 23, 2020	SELL	$72.13 - $90.25 $224,829 - $281,309	-3,117 Reduced 12.41%	22,007 $1.95 Million
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $937,394 - $1.13 Million	14,884 Added 145.35%	25,124 $1.9 Million
Q2 2019 Jul 18, 2019	BUY	$65.7 - $83.98 $28,842 - $36,867	439 Added 4.48%	10,240 $745,000
Q1 2019 Apr 17, 2019	BUY	$77.14 - $90.79 $9,796 - $11,530	127 Added 1.31%	9,801 $790,000
Q4 2018 Jan 30, 2019	BUY	$77.85 - $96.01 $32,696 - $40,324	420 Added 4.54%	9,674 $892,000
Q3 2018 Oct 09, 2018	BUY	$88.91 - $98.84 $84,197 - $93,601	947 Added 11.4%	9,254 $875,000
Q2 2018 Jul 16, 2018	BUY	$89.78 - $106.23 $440,640 - $521,376	4,908 Added 144.4%	8,307 $770,000
Q1 2018 Apr 16, 2018	SELL	$92.01 - $123.21 $192,116 - $257,262	-2,088 Reduced 38.05%	3,399 $322,000
Q4 2017 Feb 07, 2018	BUY	$89.56 - $98.21 $15,762 - $17,284	176 Added 3.31%	5,487 $531,000
Q3 2017 Nov 01, 2017	BUY	$69.85 - $89.22 $370,973 - $473,847	5,311	5,311 $472,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.

Account